Clinical Trial Update: Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating inosine (gut microbial metabolite) in combination with PD-1/PD-L1 inhibitors for patients with advanced solid tumors; status s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Inosine (gut microbial metabolite) (inosine)
• PD-1/PD-L1 inhibitor

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Advanced Solid Tumor | Phase 2, Phase 3 | Status: COMPLETED